Discontinued — last reported Q1 '21
Operating Expenses
Impairment Charges
This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ2 2016
Last reportedQ1 2021
How to read this metric
Frequent or large impairment charges signal poor capital allocation or overly optimistic historical valuations of assets.
Detailed definition
Impairment charges represent the write-down of the carrying value of assets when their fair value falls below their book...
Peer comparison
Common in cyclical industries where asset values are highly sensitive to external market price assumptions.
Metric ID:
is_impairment_chargesHistorical Data
12 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $379.00M | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | — | — | — | — | — | — | — | — | -100.0% | — | — |
Range$0.00 – $379.00M
Impairment Charges at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's impairment charges?
- Vertex Pharmaceuticals (VRTX) reported impairment charges of $0.00 in Q4 2025.
- What does impairment charges mean?
- A reduction in the recorded value of an asset because it is worth less than its book value.